skip to content

Cambridge Institute for Medical Research

 
Read more at: CIMR researcher and COVID19 expert featured in the media

CIMR researcher and COVID19 expert featured in the media

9 March 2021

CIMR's Dr Mike Weekes is also an honororary consultant in infectious diseases at Cambridge University Hospitals NHS Foundation Trust (CUH). Dr Weekes has led COVID19 screening work to control the spread of the virus and to understand the impact of vaccination programmes on the pandemic. His most recent study showed the...

Read more

Read more at: CIMR spin out company ApcinteX reports its first trial results in haemophilia

CIMR spin out company ApcinteX reports its first trial results in haemophilia

9 February 2021

Both ApcinteX and the company’s lead development drug SerpinPC, resulted from a collaboration between CIMR’s Prof. Jim Huntington and haematologist Dr Trevor Baglin (formerly of Cambridge University Hospitals). The results from AP-0101, the first human trial of SerpinPC were presented today at the 14th Annual Congress of...

Read more

Read more at: CIMR researcher recognised in 2021 New Year Honours

CIMR researcher recognised in 2021 New Year Honours

5 January 2021

Congratulations to Dr Mike Weekes who was awarded a British Empire Medal for services to the NHS during the COVID-19 pandemic. Dr Weekes developed a comprehensive COVID-19 screening programme for all Cambridge University Hospitals healthcare workers, and Cambridge University staff and students with symptoms of COVID-19. He...

Read more

Read more at: Multidisciplinary funding award for CIMR early career researcher

Multidisciplinary funding award for CIMR early career researcher

7 December 2020

Congratulations to Dr Jonathon Nixon-Abell (Sir Henry Wellcome Fellow at CIMR with Prof. Peter St George Hyslop FRS) and Dr Georg Krainer (Marie Skłodowska-Curie Fellow with Prof. Tuomas Knowles at the Department of Chemistry) who have jointly secured a Pump Priming Grant from the Cambridge Centre for Physical Biology...

Read more

CIMR experts comment on a major advance in protein research

2 December 2020

There has been wide interest in AlphaFold2, a program from Google’s DeepMind Artificial Intelligence (AI) network which was reported as having solved a long-standing challenge in biology. The incredible range of different behaviour and functions found across proteins depends upon their 3D structures - in turn, largely...

Read more

Read more at: CIMR Principal Investigator recognised as 'highly-cited researcher' in 2020

CIMR Principal Investigator recognised as 'highly-cited researcher' in 2020

19 November 2020

Professor David Rubinsztein FRS has been highlighted by the Web of Science Group as a 2020 ‘Highly Cited Researcher’ for his research on mechanisms of autophagy and neurodegeneration. This reflects analysis by Web of Science of Prof. Rubinsztein’s research publications in the years 2009 – 2019, many of which rank in the...

Read more

Read more at: Royal Society Dorothy Hodgkin Research Fellowship for CIMR early-career researcher

Royal Society Dorothy Hodgkin Research Fellowship for CIMR early-career researcher

1 October 2020

Congratulations to Dr Janin Lautenschlaeger, who will start as Royal Society Dorothy Hodgkin Research Fellow at CIMR. Her project, entitled ‘Liquid-liquid phase separation of alpha-synuclein at the presynaptic terminal’ will be carried out in Prof. Peter St George-Hyslop’s lab and focus on the recently-discovered property...

Read more

Read more at: Award for rare disease research at CIMR

Award for rare disease research at CIMR

25 September 2020

Congratulations to Dr Joseph Chambers of the Marciniak Lab, one of two winners of the 18th Annual Alpha-1-Antitrypsin Laurell’s Training Award. This global award is to support early-career researchers working on alpha-1-antitrypsin deficiency. Joseph’s project is entitled ‘Effects of alpha-1 antitrypsin polymerisation on...

Read more

Read more at: CIMR spin-out company starts first clinical trial

CIMR spin-out company starts first clinical trial

19 August 2020

Z Factor Ltd have announced that dosing has begun in a Phase I study of ZF874, their first-in-class, small molecule drug. This was discovered from research at Prof. Jim Huntington's laboratory in CIMR as a potential treatment for alpha-1-antitrypsin deficiency (AATD). Most forms of this genetic disease are caused by the...

Read more

Read more at: New Wellcome Trust Fellowship award at CIMR

New Wellcome Trust Fellowship award at CIMR

13 July 2020

Congratulations to Dr Chloe Johnson for being awarded a Sir Henry Wellcome Postdoctoral Fellowship at the CIMR. With Professor Folma Buss, Chloe will be investigating the spatial and temporal regulation of immune-specific myosin motors. In collaboration with Ludwig Maximilian University of Munich and University of Kent...

Read more